Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors.
about
Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cellsStructural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 AntigensAllorecognition by T Lymphocytes and Allograft RejectionQuantitating T cell cross-reactivity for unrelated peptide antigensThe effect of mutations on the alloreactive T cell receptor/peptide-MHC interface structure: a molecular dynamics study.Alloreactivity: an old puzzle revisited.Cellular immune dysfunction in immune thrombocytopenia (ITP).The standard model of T-cell receptor function: a critical reassessment.The hidden maternal-fetal interface: events involving the lymphoid organs in maternal-fetal tolerance.Detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assayExpanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responsesNew insights into the functions of B cellsAntigen/major histocompatibility complex-specific activation of murine T cells transfected with functionally rearranged T-cell receptor genes.Evolving concepts of specificity in immune reactionsDevelopment of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms.The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein.Killer cells reactive to altered-self antigens can also be alloreactiveAt the crossroads between tolerance and aggression: Revisiting the "layered immune system" hypothesis.Functional clonal deletion in immunological tolerance to major histocompatibility complex antigens.Environmental and genetic control of T cell activation in vitro: a study using isolated alloantigen-activated T cell clones.Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.Rapid quantification of naive alloreactive T cells by TNF-alpha production and correlation with allograft rejection in mice.High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins.Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.Histocompatibility antigen-activated cytotoxic T lymphocytes. I. Estimates of the absolute frequency of killer cells generated in vitro.Cytotoxic T cells distinguish between trinitrophenyl- and dinitrophenyl-modified syngeneic cells.Quantitative studies on the precursors of cytotoxic lymphocytes. III. The lineage of memory cells.Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses.Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigensBinding of purified, soluble major histocompatibility complex polypeptide chains onto isolated T-cell receptors. I. Reactivity against allo- and self-determinants.The receptor specificity of alloreactive T cells. Distinction between stimulator K, I, and D region products and degeneracy of third-party H-2 recognition by low-affinity T cells.Role of self and foreign antigenic determinants in allogeneic and self-restricted cytotoxic T cell recognitionFrequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysisAnalysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2Quantitative studies on T cell diversity. III. Limiting dilution analysis of precursor cells for T helper cells reactive to xenogeneic erythrocytes.Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis.An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.The murine MHC class I genes, H-2Dq and H-2Lq, are strikingly homologous to each other, H-2Ld, and two genes reported to encode tumor-specific antigens.
P2860
Q26851647-FAE1FBB8-1F40-49CC-A6B8-5B16BAF94156Q27646543-E8710EBC-0781-4C18-B78C-8C1D8A222065Q28067365-59F1DDCE-A0A6-42A0-85AE-56741A7201AAQ28750512-FA78C745-C2B7-490E-AA2A-08F5D074DB5DQ33351448-A5988948-8860-4155-8F62-6285A3A623E0Q33352808-0EEA6908-E7FA-4908-A555-EBD9439DFCCBQ33409710-EBB4B660-C627-4D9B-B8A5-D69C603AB75CQ33650391-C419825F-326B-4543-88BF-6E38B468C6CFQ33756987-8AD55D53-CFE9-4FD3-9C77-ED760EC6C93CQ33785850-B8E9B3D5-945A-4321-89A0-C310C5F33284Q33867766-37791190-9794-43E0-876E-FCF65A88798AQ33936014-F310CE01-D09A-40ED-A105-E70F18BD081DQ34359698-77CA1A69-7897-4136-9188-C11DF6994DE3Q34450109-FB69137E-3D27-4A15-853F-7F8DAE4500C7Q34478717-8D56240F-8F75-4AEB-B21C-CEEB03709A66Q34650563-D330CADF-8D30-4E48-9F59-E186826E9BC7Q35027922-8A454D0C-DF9C-4BA1-881D-C7778454DA97Q35194849-0325FBA7-8F9F-4D26-8D27-D61F5E159109Q35386478-3F972B4D-6A21-46DB-8827-981411D36053Q35497321-4FB455E3-D074-4F12-AC41-4AE9FF5F7148Q35547588-AEC30954-5A9A-4F09-A068-9B34964D4D84Q35615865-24078FA9-72C7-4713-9923-D1BD743640BBQ35918289-82ED32B9-A34B-4648-87BB-2C684EBAF6D6Q36011368-614C2454-5BAC-4CD7-A3A4-13897660D4AEQ36335552-39D64561-3627-429F-BBBA-688C4CC98E54Q36335686-E5696EC2-F959-4D83-923B-91823CD72924Q36336189-3E4B8A9C-0E35-4C54-98B3-4504B40501BEQ36341051-6E13BF24-5655-4EE6-ACCF-8D6714D45AF5Q36341767-5794946B-2E7D-4776-9398-546850192D4AQ36342063-2F705C49-8BA6-4601-86EF-AC6BE5759FA3Q36342963-9B136FBA-8C10-4B6E-8967-66DC076B8D5FQ36343181-9CCA8089-82C1-469E-96DB-B4CCB48874CDQ36343953-C975DEDE-4E9B-45E9-B7EE-24C4C8BF03F2Q36344422-A57AC814-55A5-4744-8ACD-8D1756DA68F4Q36345524-96BBED04-B436-4233-B067-480974075490Q36347166-72F35136-E226-4542-9AA7-D2833B57B18BQ36348326-5247CD4C-1870-4EE1-8510-11D3A9C74547Q36353874-9A63A656-174E-48FB-AA75-422D8E0D5AB1Q36355134-3CF94E3A-0AD8-4F0A-9E10-2CF3ACCA7AD9Q36355584-11853FA5-68A6-4B79-881A-449F570D2B1E
P2860
Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Histocompatibility antigen-act ...... and specificity of precursors.
@ast
Histocompatibility antigen-act ...... and specificity of precursors.
@en
type
label
Histocompatibility antigen-act ...... and specificity of precursors.
@ast
Histocompatibility antigen-act ...... and specificity of precursors.
@en
prefLabel
Histocompatibility antigen-act ...... and specificity of precursors.
@ast
Histocompatibility antigen-act ...... and specificity of precursors.
@en
P2860
P356
P1476
Histocompatibility antigen-act ...... and specificity of precursors.
@en
P2093
D B Wilson
K F Lindahl
P2860
P304
P356
10.1084/JEM.145.3.508
P407
P577
1977-03-01T00:00:00Z